Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer. [electronic resource] by
- Mego, M
- Svetlovska, D
- Chovanec, M
- Rečkova, M
- Rejlekova, K
- Obertova, J
- Palacka, P
- Sycova-Mila, Z
- De Giorgi, U
- Mardiak, J
Producer: 20200206
In:
Investigational new drugs vol. 37
Availability: No items available.
|
|
|
19.
|
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. [electronic resource] by
- Mardiak, J
- Sálek, T
- Sycová-Milá, Z
- Obertová, J
- Recková, M
- Mego, M
- Hlavatá, Z
- Brozmanová, K
- Risnyovzská, Z
- Svetlovská, D
- Koza, I
Producer: 20070628
In:
Neoplasma vol. 54
Availability: No items available.
|